ANALYST-UPGRADE

GILD

GILEAD SCIENCES, INC.
BULLISH
Impact 2/10
Processed4mo ago SECanalyst-GILD-maximgro-20260520
Maxim Group double upgrade: Hold → Buy
Actionable Insight ▲ Bullish

Maxim's double upgrade adds to the bullish chorus but comes from a low-accuracy firm against a backdrop of insider selling and deteriorating near-term EPS. Traders should treat this as a mild positive catalyst, focusing on the strong consensus and high short interest for potential squeeze dynamics, but avoid over-weighting the call given the mixed cross-platform signals.

DirectionBullish
Final — all horizons settled through T+60d
GILD ▲ +5.91% at T+60d
LONG call ✓ call won +5.91% · α vs SPY +1.18% · entry $130.61 → $138.33
Entry anchored
May 20, 09:42 AM ET
via exchange tick
T+1d
-0.15%
call -0.15% · α -0.35%
$130.41
settled 4mo ago
T+5d
+2.36%
call +2.36% · α +1.12%
$133.69
settled 4mo ago
T+20d
-3.95%
call -3.95% · α -3.91%
$125.45
settled 4mo ago
T+60d
+5.91%
call +5.91% · α +1.18%
$138.33
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Maxim Group double-upgraded GILD from Hold to Buy with a $165 price target, implying 26.4% upside from $130.50. The call is contrarian against a backdrop of insider selling and recent EPS estimate cuts, but aligns with an overwhelmingly bullish consensus (31 Buy, 8 Hold, 0 Sell). Maxim’s track record is 43% accurate on 305 calls, well below the average of top-tier firms covering the stock. At $157.57 mean PT, the street sees ~20.7% upside; Maxim’s $165 sits above mean. Over the last 30 days, GILD has seen 1 upgrade and 0 downgrades, but EPS revisions for the current year have been slashed 20 times (0 up). Insider sales totaling ~$3.1M in April–May from C-suite officers (CFO, EVP) diverge bearishly from the upgrade. Short interest stands at a high 55.2% of float, suggesting elevated bearish positioning. Bottom line: the upgrade is a positive trigger, but low analyst accuracy, insider selling, and deteriorating near-term estimates warrant caution despite the bullish consensus.

Impact Score

Base Score
1/7
LLM Adjustment
+1
Final Score
2/10

Consensus & Targets

Buy / Strong Buy
31 (79%)
Hold
8
Sell / Strong Sell
0
Total Analysts
28
Mean PT
$157.57
Median PT
$160.00
High PT
$180.00
Low PT
$122.00
Current Price
$130.50
Implied Upside
+20.7%

Consensus is heavily bullish: of 39 analysts, 31 rate Buy (including 11 Strong Buy), 8 Hold, and 0 Sell. This is a strong directional consensus, with no bears. Maxim's upgrade aligns with the majority but comes from a lower-accuracy shop.

Current price $130.50. Mean PT is $157.57, median $160, high $180, low $122. Implied upside to mean is 20.7%. Maxim's $165 is above the mean and median, ranking in the upper quartile. The high PT of $180 from Jefferies (initiated in March) suggests further upside potential if catalysts materialize.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-05-20Maxim GroupupgradeBuy$165.00
2026-05-08Truist SecuritiesreiterateBuy$157.00
2026-05-08RBC CapitalmaintainSector Perform$122.00
2026-04-13CitigroupmaintainBuy$165.00
2026-04-10Morgan StanleymaintainOverweight$175.00
2026-03-10JefferiesinitiateBuy$180.00
2026-02-23NeedhamreiterateBuy$170.00
2026-02-20BarclaysinitiateEqual-Weight$155.00
2026-02-11RBC CapitalmaintainSector Perform$118.00
2026-02-11Truist SecuritiesmaintainBuy$152.00

30-day analyst activity: 1 upgrade (this one), 0 downgrades. EPS revision trend is mixed: current-quarter EPS estimates have 13 downward revisions in 30 days (0 up), and current-year estimates have 20 down (0 up). However, next-quarter and next-year estimates show more balanced revisions (6 up / 0 down and 7 up / 12 down, respectively). The near-term outlook is deteriorating, but forward-looking estimates remain more resilient.

Firm Track Record — Maxim Group

Maxim Group accuracy: 43% on 305 calls | avg return: 5.9%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Truist Securities100%4/49.7%top tier
TD Cowen100%2/216.2%top tier
Citigroup100%2/28.3%top tier
UBS100%3/311.5%top tier
Mizuho100%2/216.8%top tier
RBC Capital93%13/1414.9%top tier
Needham89%8/912.2%top tier
BMO Capital86%6/77.6%top tier
JP Morgan86%6/76%top tier
Cantor Fitzgerald86%6/717.9%top tier

Maxim Group has a 43% accuracy rate on 305 calls with an average return of 5.9%. This is well below top-tier firms like Truist (100% on 4 calls), RBC Capital (93% on 14 calls), and Cantor Fitzgerald (86% on 7 calls returning 17.9%). Best performers: TD Cowen (100%, +16.2% avg), Mizuho (100%, +16.8%). Worst: Maxim itself. The double upgrade carries less weight given this track record.

Earnings Estimates

Next earnings: Aug 5, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$-6.63$-7.60 — $-1.31$7.4B↑0 ↓0
+1q$1.83$-0.89 — $2.57$7.8B↑6 ↓0
0y$-0.81$-1.05 — $-0.65$30.5B↑1 ↓0
+1y$9.59$8.11 — $11.15$32.3B↑7 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
NORGES BANK — new
Institutional
TWO SIGMA INVESTMENTS, LP — new
Institutional
RENAISSANCE TECHNOLOGIES LLC — trim (-49%)
Short Interest
Short: 1,793,633 | Exempt: 14,098 | TRF Vol: 3,247,537 | Short Ratio: 55.2% | Off-exchange volume (dark pool + OTC)

Insider trades: Five sells in April–May totaling ~$3.1M from CFO Mercier (two sells) and EVPs Dickinson and O'Day. These sales are consistent with routine vesting/10b5-1 patterns but diverge bearishly from the upgrade. Institutional moves: Norges Bank opened a $2.6B position then exited entirely; Two Sigma initiated; Renaissance trimmed 49%; Ariel trimmed 41%. This mixed institutional activity offers no clear confirmation. Short interest: 55.2% of float, a high level indicating significant bearish positioning that could fuel a squeeze if positive catalysts hit. No congressional trades. Overall, the analyst bullish signal is partially offset by insider selling and institutional churn.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

16 reports for GILD
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +16.72%Jul 6, 2026
Filters
Rows
Reports for GILD — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$149.61 $149.05▼ −0.37%▼ −0.04%$144.74 (−3.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$145.68 $152.21▲ +4.48%▲ +4.22%$144.74 (−0.65%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$146.74 $152.67▲ +4.04%▲ +2.73%$144.74 (−1.36%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$147.60 $150.89▲ +2.23%▲ +4.18%$144.74 (−1.94%)
Aug 18, 2026
6w ago
Court Ruling
BULLISH ★ 7/10
$143.44 $147.68▲ +2.96%▲ +4.27%$144.74 (+0.91%)
Aug 13, 2026
7w ago
Court Ruling
BULLISH ★ 6/10
$138.14 $143.72▲ +4.04%▲ +5.79%$144.74 (+4.78%)
Aug 6, 2026
8w ago
S-3ASR
NEUTRAL ★ 2/10
$133.21 $151.00▲ +13.35%▲ +13.75%$144.74 (+8.66%)
Jul 21, 2026
10w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$130.28 $143.44▼ −10.10%▼ −7.54%$144.74 (−11.10%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$134.28 $138.33▲ +3.02%▼ −1.43%$144.74 (+7.79%)
Jul 6, 2026
12w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$129.61 $130.21▲ +0.46%▲ +1.03%$144.74 (+11.67%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 20, 2026